These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6274022)

  • 1. Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats.
    Brady KT; Balster RL; May EL
    Science; 1982 Jan; 215(4529):178-80. PubMed ID: 6274022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of N-allylnormetazocine on electric shock titration in squirrel monkeys.
    Slifer BL; Dykstra LA
    Alcohol Drug Res; 1987; 7(4):217-24. PubMed ID: 3030339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of stereoisomers of cyclazocine in phencyclidine-trained squirrel monkeys.
    Brady KT; Balster RL
    Life Sci; 1982 Aug; 31(6):541-9. PubMed ID: 6290818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
    Katz JL; Spealman RD; Clark RD
    J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
    Zukin SR; Brady KT; Slifer BL; Balster RL
    Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL; Dykstra LA
    Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):522-8. PubMed ID: 6306209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of selected opiates and phencyclidine in the nondependent and cyclazocine-dependent rhesus monkey.
    Bergman J; Hassoun J; Schuster CR
    J Pharmacol Exp Ther; 1985 Nov; 235(2):463-9. PubMed ID: 4057082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats.
    Shannon HE
    Eur J Pharmacol; 1982 Oct; 84(3-4):225-8. PubMed ID: 7173321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral self-administration of N-allylnormetazocine (SKF-10,047) stereoisomers in rhesus monkeys: substitution during phencyclidine self-administration and withdrawal.
    Carroll ME
    Pharmacol Biochem Behav; 1988 Jun; 30(2):493-500. PubMed ID: 3174781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.
    Greenberg BD; Segal DS
    Psychopharmacology (Berl); 1986; 88(1):44-53. PubMed ID: 3003779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
    Nabeshima T; Hiramatsu M; Kameyama T
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.
    Iwamoto ET
    Psychopharmacology (Berl); 1986; 89(2):221-9. PubMed ID: 3088640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats.
    Brady KT; Balster RL
    Pharmacol Biochem Behav; 1982 Aug; 17(2):291-5. PubMed ID: 7134239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF; Tam SW; Cook L
    Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms.
    Stafford I; Tomie A; Wagner GC
    Drug Alcohol Depend; 1983 Oct; 12(2):151-6. PubMed ID: 6317323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
    Sanger DJ; Jackson A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.